<qa>  What is the primary objective of the study?The primary objective is to compare the efficacy of two different doses of cis-UCA 2.5 and 5 with placebo for up to 28 days in adult patients with moderate or severe chronic atopic dermatitis to determine the dose of cis-UCA for further clinical development. 